000			02163nas a22003135i 4500
001			2168-4804
003			DE-He213
005			20260610082524.0
007			cr nn 008mamaa
008			190822s||||||||sz uu poo|||||| b|EN |d
022			_a2168-4804
024	7		_a43441 _2local
210	1	0	_aTher Innov Regul Sci
245	1	0	_aTherapeutic Innovation & Regulatory Science _h[electronic resource] / _cedited by Gregory W Daniel.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer.
300			_bonline resource.
520			_aTherapeutic Innovation & Regulatory Science (TIRS) publishes peer-reviewed original research, review articles, commentaries, and letters to the editor on medical product discovery, development, regulation, access, and policy. As the official scientific journal of the Drug Information Association (DIA), TIRS provides a unique platform for researchers, regulators, developers, patient advocacy groups, payers, and other healthcare decision-makers from around the globe to convert scientific innovations and tools from across the entire medical product lifecycle into practical solutions that advance human health. The journal focuses on the following areas: Biostatistics Clinical Trials Product Development and Innovation Regulatory Science and Policy Medical Product Value, Pricing, and Payment Reforms Coverage and Access Policy Patient Engagement and Patient-Centered Product Development Diversity and Inclusion from early clinical development to access Pharmacovigilance and Product Safety Real World Evidence (RWE) Development and Use in Regulatory and Access Decision-Making This journal is a member of the Committee on Publication Ethics (COPE).
650		0	_aPharmacy.
650		0	_aPharmacovigilance.
650		0	_aTherapeutics.
650	1	4	_aPharmacy.
650	2	4	_aDrug Safety and Pharmacovigilance.
650	2	4	_aTherapeutics.
700	1		_aDaniel, Gregory W. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x2168-4790
856	4	0	_uhttp://link.springer.com/journal/43441 _zHybrid
999			_c3830 _d3830